Investment Team Stockholm

Ulrica has the overall responsibility for Arctic Aurora LifeScience investment portfolio. She has ca 30 years of successful track record as a Portfolio Manager in Health Care and has been a top ranked Health care Analyst for (10 years). Ulrica has an MBASc, CEFA, with a degree from Stockholm School of Economics and Medicine at the Karolinska Institute..

Mr. Torbjørn Bjerke is a Medical Doctor with the responsibility of scientific, clinical and regulatory due dilligence of new opportunities and portfolio management in Arctic Aurora LifeScience. He has more than 30 years of executive experience within successful drug development and business development/M&A in both public and private science companies. Mr. Bjerke got his doctor degree from the University of Aarhus.

Daniel fills the role as an analyst in Arctic Aurora LifeScience with the responsibility of reaserch, value tracking. valuation, opportunity sourcing. He has more than 5 years experience as business analyst and has had several engagements for small biotech/medtech companies.Daniel has a MSc (Biotech) and a MSc (Business/Economics) from the University of Uppsala.

As analyst in team, Mark Fabian’s work focus is company modelling, but also evaluation of products and pipelines in pharma and biotech companies as well as individual companies. Mark has multiple years of experience in drug discovery, pharmaceutical and computational chemistry. Completed internships at Roche, DNB and Amgen Scholars Program. Analyst at Arctic since 2021. Educated at Semmelweis University (PharmD) and Karolinska Institutet (MSc in Bioentrepreneurship).